ROLAPITANT | ROLAPITANT | ATC A04AD14
NERVOUS SYSTEM TREATMENT OF NAUSEA AND VOMITING INDUCED BY CANCER CHEMOTHERAPY SUBSTANCE P/NEUROKININ 1 (NK1) RECEPTOR ANTAGONIST | ORAL INTRAVENOUS | Cmax 1.9 MICROMOLAR Tmax 4 HOUR VD 460 LITER PPB 99.8 PERCENT Cl 0.96 LITER / HOUR HT 176 HOUR | P/NEUROKININ-1 (NK1) RECEPTOR | Substance-P receptor UNIPROT P25103 TACR1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |